Ginkgo Bioworks (DNA) Registration Filing summary

Company overview and business model

• Builds tools to make biology easier to engineer, offering customizable R&D solutions, modular lab automation, and large-scale data generation for AI models.

• Provides biosecurity infrastructure and technologies for detecting and identifying biological threats.

Use of proceeds and capital allocation

• Net proceeds from securities sales will be used as set forth in the applicable prospectus supplement for each offering.

Risk factors and disclosures

• Highlights high degree of risk, referencing detailed risk factors in recent annual and quarterly SEC filings.

• Risks include competition, technology changes, regulatory compliance, customer reliance, and market conditions.

• Forward-looking statements are subject to uncertainties and actual results may differ materially.